Description
Cervical cancer is the most common malignancy among women particularly in developing countries, with human papillomavirus (HPV) 16 causing 50% of invasive cervical cancers. A plant-based HPV vaccine is an alternative to the currently available virus-like particle (VLP) vaccines, and would be much less expensive.
Copyright Statement
Reuse Permissions
Download count: 0
Details
Contributors
- Zahin, Maryam (Author)
- Joh, Joongho (Author)
- Khanal, Sujita (Author)
- Husk, Adam (Author)
- Mason, Hugh (Author)
- Warzecha, Heribert (Author)
- Ghim, Shin-je (Author)
- Miller, Donald M. (Author)
- Matoba, Nobuyuki (Author)
- Bennett Jenson, Alfred (Author)
- ASU Biodesign Center Immunotherapy, Vaccines and Virotherapy (Contributor)
- Biodesign Institute (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2016-08-12
Resource Type
Collections this item is in
Identifier
- Digital object identifier: 10.1371/journal.pone.0160995
- Identifier TypeInternational standard serial numberIdentifier Value1045-3830
- Identifier TypeInternational standard serial numberIdentifier Value1939-1560
Note
- The article is published at http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160995, opens in a new window
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Zahin, M., Joh, J., Khanal, S., Husk, A., Mason, H., Warzecha, H., . . . Jenson, A. B. (2016). Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves. Plos One, 11(8). doi:10.1371/journal.pone.0160995